Literature DB >> 2692753

Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord.

H Shinozaki1, M Ishida, K Shimamoto, Y Ohfune.   

Abstract

1. Neuropharmacological actions of all possible-state isomers of alpha-(carboxycyclopropyl)glycine (CCG), conformationally restricted analogues of glutamate, were examined for electrophysiological effects in the isolated spinal cord of the newborn rat. 2. Eight CCG stereoisomers demonstrated a large variety of depolarizing activities. Among them, the (2R, 3S, 4S) isomers of CCG (D-CCG-II) showed the most potent depolarizing activity, followed by the (2S, 3R, 4S) isomer (L-CCG-IV). 3. The depolarization evoked by L-CCG-IV, D-CCG-II and other D-CCG isomers was effectively depressed by N-methyl-D-aspartate (NMDA) antagonists. D-CCG-II was about 5 times more potent than NMDA in causing a depolarization. 4. The (2S, 3S, 4S) isomer of CCG (L-CCG-I) was more potent than L-glutamate in causing a depolarization of spinal motoneurones. The depolarization was slightly depressed by NMDA antagonists, but residual amplitudes of responses to L-CCG-I in the presence of NMDA antagonists We almost insensitive to 6,7-dinitro-quinoxaline-2,3-dione (DNQX) or 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), suggesting that L-CCG-I might be a novel potent agonist. 5. After application of the (2S, 3S, 4R) isomer of CCG (L-CCG-III), responses to L-glutamate, D- and L-aspartate were markedly enhanced. The enhancement lasted for a period of several hours without a further application of L-CCG-III. 6. L-CCG-III also caused a depolarization, but it seemed unlikely that the potentiation of the glutamate response was directly related to the depolarization evoked by L-CCG-III. 7. The potentiation might be due to inhibition of uptake processes, but L-CCG-III was superior to L-(-)-threo-3-hydroxyaspartate, a potent uptake inhibitor of L-glutamate and L-aspartate, in enhancing the response to L-glutamate in terms of amplitude and duration of responses. 8. CCG isomers should provide useful pharmacological tools for analysis of glutamate neurotransmitter systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692753      PMCID: PMC1854833          DOI: 10.1111/j.1476-5381.1989.tb12667.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Stereospecificity of the inhibition of L-glutamate and L-aspartate high affinity uptake in rat brain slices by threo-3-hydroxyaspartate.

Authors:  V J Balcar; G A Johnston; B Twitchin
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

2.  The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices.

Authors:  V J Balcar; G A Johnston
Journal:  J Neurochem       Date:  1972-11       Impact factor: 5.372

Review 3.  Excitatory amino acid transmitters.

Authors:  J C Watkins; R H Evans
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

4.  Coupled transport of glutamate and sodium in a cerebellar nerve cell line.

Authors:  W B Stallcup; K Bulloch; E E Baetge
Journal:  J Neurochem       Date:  1979-01       Impact factor: 5.372

5.  Action of the neurotoxin kainic acid on high affinity uptake of L-glutamic acid in rat brain slices.

Authors:  G A Johnston; S M Kennedy; B Twitchin
Journal:  J Neurochem       Date:  1979-01       Impact factor: 5.372

6.  Potentiation of L-glutamate and L-aspartate excitation of cat spinal neurones by the stereoisomers of threo-3-hydroxyaspartate.

Authors:  G A Johnston; D Lodge; J C Bornstein; D R Curtis
Journal:  J Neurochem       Date:  1980-01       Impact factor: 5.372

7.  A conformationally restricted analogue of L-glutamate, the (2S,3R,4S) isomer of L-alpha-(carboxycyclopropyl)glycine, activates the NMDA-type receptor more markedly than NMDA in the isolated rat spinal cord.

Authors:  H Shinozaki; M Ishida; K Shimamoto; Y Ohfune
Journal:  Brain Res       Date:  1989-02-20       Impact factor: 3.252

8.  2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation.

Authors:  J Davies; A A Francis; A W Jones; J C Watkins
Journal:  Neurosci Lett       Date:  1981-01-01       Impact factor: 3.046

9.  Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations.

Authors:  B Ault; R H Evans; A A Francis; D J Oakes; J C Watkins
Journal:  J Physiol       Date:  1980-10       Impact factor: 5.182

10.  Inhibitory action of ibotenic acid on the crayfish neuromuscular junction.

Authors:  H Shinozaki; M Ishida
Journal:  Brain Res       Date:  1980-09-29       Impact factor: 3.252

View more
  6 in total

1.  Novel kainate derivatives: potent depolarizing actions on spinal motoneurones and dorsal root fibres in newborn rats.

Authors:  M Ishida; H Shinozaki
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

2.  NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acid.

Authors:  F Moroni; A Galli; G Mannaioni; V Carla; A Cozzi; F Mori; M Marinozzi; R Pellicciari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

3.  Pharmacological characterization of the metabotropic glutamate receptor inhibiting D-[3H]-aspartate output in rat striatum.

Authors:  G Lombardi; M Alesiani; P Leonardi; G Cherici; R Pellicciari; F Moroni
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

4.  A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord.

Authors:  M Ishida; T Saitoh; K Shimamoto; Y Ohfune; H Shinozaki
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells.

Authors:  Y Hayashi; Y Tanabe; I Aramori; M Masu; K Shimamoto; Y Ohfune; S Nakanishi
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

6.  A novel antagonist, phenylbenzene omega-phosphono-alpha-amino acid, for strychnine-sensitive glycine receptors in the rat spinal cord.

Authors:  T Saitoh; M Ishida; M Maruyama; H Shinozaki
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.